Skip to search formSkip to main contentSkip to account menu

Metformin

Known as: Metformine, Dimethylbiguanid, Imidodicarbonimidic diamide, N,N-dimethyl- 
An agent belonging to the biguanide class of antidiabetics with antihyperglycemic activity. Metformin is associated with a very low incidence of… 
National Institutes of Health

Related topics

Related topics

41 relations
24 HR Metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet [Kombiglyze]24 HR Metformin hydrochloride 1000 MG / sitagliptin 50 MG Extended Release Oral Tablet [Janumet]24 HR Metformin hydrochloride 500 MG Extended Release Oral TabletBiguanides

Narrower (11)

AvandametCidophageGlucinanGlucovance

Broader (1)

Hypoglycemic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.
Highly Cited
2007
Highly Cited
2007
Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration.
AMP-activated protein kinase (AMPK) acts as a cellular energy sensor: it responds to an increase in AMP concentration ([AMP]) or… 
Highly Cited
2004
Highly Cited
2004
Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization.
Review
2003
Review
2003
Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.
Glucagon-like peptide-1-(7-36)-amide (GLP-1) is a potent blood glucose-lowering hormone now under investigation for use as a… 
Review
2002
Review
2002
The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.
Highly Cited
2001
Highly Cited
2001
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus
Gastrointestinal symptoms are commonly reported as side‐effects of oral hypoglycaemic drugs. It may be very difficult to… 
Review
2001
Review
2001
Insulin-lowering drugs in polycystic ovary syndrome.
Highly Cited
1999
Highly Cited
1999
Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy.
Review
1995
Review
1995
Lessons from UK prospective diabetes study.
Highly Cited
1967
Highly Cited
1967
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)